“…Juan Jin et al 73 identified biomarkers, including CTLA-4, CXCR3, CCR4, CD39, PD-1, and HLA-DR, via mass cytometry (CyTOF) analysis, which are associated with significantly altered monocyte, T cell, and B cell subpopulations in early-stage DKD; however, further validation in other cohorts is necessary. Shaojie Fu et al 121 used three different algorithms, including least absolute shrinkage and selection operator (LASSO), support vector machine-recursive feature elimination (SVM-RFE), and random forest (RF), to identify DUSP1 and PRKAR2B as possible biomarkers. Further, immunohistochemical staining indicated that DUSP1 and PRKAR2B expression levels were significantly decreased in patients with DKD.…”